Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome - Related Studies

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

This study is ongoing, but not recruiting participants.

Study NCT00002800. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer-Related Problem/Condition
		Leukemia
		Myelodysplastic Syndromes

2	Additional conditions recognized in this trial
		Leukemia, Myelogenous, Chronic, BCR-ABL Positive
		Leukemia, Myeloid
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Bone Marrow Diseases
		Disease
		Hematologic Diseases
		Myeloproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Pathologic Processes
		Precancerous Conditions

4	Interventions listed in this trial
		cytarabine
		etoposide
		filgrastim
		idarubicin
		lintuzumab

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antiviral Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Memorial Sloan-Kettering Cancer Center
		National Cancer Institute (NCI)